Public Health Detailing for Human Immunodeficiency Virus Pre-exposure Prophylaxis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30020422.
- Also identified by DOI 10.1093/cid/ciy573.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Despite the promise of human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP), PrEP remains underutilized, often due to clinician factors. Academic or public health detailing is a process by which university and/or government groups employ the marketing practices of pharmaceutical companies to improve clinical practice. We describe the novel application of detailing to increase PrEP prescribing and related care in New York City and New England. Detailing can play a crucial role in PrEP implementation.
Medical subject headings
- Anti-HIV Agents
- Drug Prescriptions
- HIV Infections
- Pre-Exposure Prophylaxis
- Public Health